Perri, Maria Teresa
 Distribuzione geografica
Continente #
NA - Nord America 105
EU - Europa 74
AS - Asia 32
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 213
Nazione #
US - Stati Uniti d'America 105
IT - Italia 27
IE - Irlanda 15
CN - Cina 14
SE - Svezia 10
SG - Singapore 10
DE - Germania 6
FR - Francia 4
KR - Corea 4
IN - India 3
NL - Olanda 3
RU - Federazione Russa 3
GB - Regno Unito 2
MK - Macedonia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AT - Austria 1
BR - Brasile 1
FI - Finlandia 1
TW - Taiwan 1
Totale 213
Città #
Ashburn 25
Chandler 15
Dublin 15
Rome 9
New York 6
Singapore 6
Milan 5
New Haven 4
Washington 4
Amsterdam 3
Beijing 3
Boston 3
Busto Arsizio 3
Jeju City 3
Wilmington 3
Bari 2
Erie 2
Moscow 2
Nave 2
Paris 2
Princeton 2
San Mateo 2
Antwerp 1
Asti 1
Bremen 1
Cagliari 1
Dearborn 1
Guidonia Montecelio 1
Hebei 1
Jacksonville 1
Lappeenranta 1
Marseille 1
Mountain View 1
Nanjing 1
Ningbo 1
Portland 1
San Francisco 1
Suyeong-gu 1
São Paulo 1
Taipei 1
Tappahannock 1
Vienna 1
Totale 141
Nome #
Laparoscopic versus robotic hysterectomy in obese and extremely obese patients with endometrial cancer: A multi-institutional analysis 54
Immunotherapy-related imaging findings in patients with gynecological malignancies: What radiologists need to know 40
Survival outcomes in patients with BRCA mutated, variant of unknown significance, and wild type ovarian cancer treated with PARP inhibitors 33
Combining PARP inhibition and immune checkpoint blockade in ovarian cancer patients: a new perspective on the horizon? 22
Recent progress in the use of pharmacotherapy for endometrial cancer 22
Advanced and recurrent endometrial cancer: State of the art and future perspectives 17
Preclinical and Clinical Evidence of Lurbinectedin in Ovarian Cancer: Current Status and Future Perspectives 16
Survival outcomes in patients with BRCA mutated, variant of unknown significance, and wild type ovarian cancer treated with PARP inhibitors 13
Survival outcomes in patients with BRCA mutated, variant of unknown significance, and wild type ovarian cancer treated with PARP inhibitors 6
Totale 223
Categoria #
all - tutte 1.497
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.497


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20207 2 0 1 0 0 0 2 0 0 0 2 0
2020/20212 0 0 0 0 0 1 0 0 0 0 1 0
2021/202213 0 0 0 1 0 0 0 4 0 1 3 4
2022/202374 6 6 1 7 2 7 2 1 11 7 18 6
2023/2024117 2 22 14 11 6 15 16 1 4 3 13 10
2024/20256 6 0 0 0 0 0 0 0 0 0 0 0
Totale 223